Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,152Revenue $M218Net Margin (%)0Z-Score0
Enterprise Value $M1,983EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with SNTS

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNTSJohn Paulson 2014-03-31 Sold Out -0.79%$31.96 - $31.97
($31.97)
$ 31.960%Sold Out0
SNTSMario Gabelli 2014-03-31 Sold Out -0.07%$31.96 - $31.97
($31.97)
$ 31.960%Sold Out0
SNTSJoel Greenblatt 2014-03-31 Sold Out -0.02%$31.96 - $31.97
($31.97)
$ 31.960%Sold Out0
SNTSJohn Paulson 2013-12-31 Buy 0.79%$21.05 - $32.18
($28.12)
$ 31.9614%New holding, 5000000 sh.5,000,000
SNTSMario Gabelli 2013-12-31 Buy 0.07%$21.05 - $32.18
($28.12)
$ 31.9614%New holding, 392700 sh.392,700
SNTSJoel Greenblatt 2013-12-31 Reduce-0.03%$21.05 - $32.18
($28.12)
$ 31.9614%Reduce -62.26%25,257
SNTSJoel Greenblatt 2013-09-30 Buy 0.05%$21.17 - $27.26
($23.84)
$ 31.9634%New holding, 66922 sh.66,922
SNTSGeorge Soros 2011-09-30 Sold Out -0.0013%$2.49 - $3.39
($3.07)
$ 31.96941%Sold Out0
SNTSGeorge Soros 2011-06-30 Add$3.03 - $3.48
($3.22)
$ 31.96892%Add 46.35%28,100
SNTSGeorge Soros 2011-03-31 Buy $3.14 - $3.69
($3.32)
$ 31.96863%New holding, 19200 sh.19,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNTS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SNTS Joel Greenblatt 2014-03-310 0Sold Out
SNTS John Paulson 2014-03-310 0Sold Out
SNTS Mario Gabelli 2014-03-310 0Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


SNTS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PROEHL GERALD TPresident & CEO 2013-12-16Sell56,643$31.950.03view
SNYDER KENTDirector 2013-12-16Sell7,500$31.950.03view
DE MEULES JULIE ASr. VP, Human Resources 2013-12-09Sell15,165$31.950.03view
PROEHL GERALD TPresident & CEO 2013-11-15Sell56,644$32.02-0.19view
SNYDER KENTDirector 2013-11-15Sell7,500$32.01-0.16view
DE MEULES JULIE ASr. VP, Human Resources 2013-11-11Sell15,165$31.940.06view
PROEHL GERALD TPresident & CEO 2013-10-15Sell50,000$22.3243.19view
SNYDER KENTDirector 2013-10-15Sell7,500$22.3143.25view
CRAWFORD DEBRA PSr. VP, CFO, Sec'y, Treas 2013-10-10Sell16,614$21.945.94view
DE MEULES JULIE ASr. VP, Human Resources 2013-10-09Sell15,165$21.1451.18view

Press Releases about SNTS :

    Quarterly/Annual Reports about SNTS:

    News about SNTS:

    Articles On GuruFocus.com
    Mario Gabelli Comments on Valassis Communications Apr 30 2014 
    Mario Gabelli Comments on Santarus Inc. Apr 30 2014 
    Mario Gabelli's ABC Fund First Quarter 2014 Letter Apr 30 2014 
    Mario Gabelli’s Top 5 Fourth-Quarter Stock Buys Feb 07 2014 
    comment on SNTS Mar 06 2013 
    comment on SNTS Mar 02 2013 
    Santarus Inc. Reports Operating Results (10-K) Mar 04 2011 
    Santarus Inc. Reports Operating Results (10-Q) Nov 09 2010 
    Santarus Inc. Reports Operating Results (10-Q) Aug 03 2010 
    Santarus Inc. Reports Operating Results (10-Q) May 07 2010 

    More From Other Websites
    Salix Pharmaceuticals Completes Acquisition of Santarus Jan 02 2014
    SANTARUS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a... Jan 02 2014
    RedHill Biopharma Sells ADS Dec 31 2013
    Pipeline Setback at Can-Fite BioPharma, Shares Down Dec 31 2013
    Santarus Announces Availability of Amended Tender Offer Materials Dec 30 2013
    Santarus Announces Availability of Amended Tender Offer Materials Dec 30 2013
    Durata Progresses with Dalbavancin Dec 27 2013
    Pipeline Update on Aratana Dec 27 2013
    Update on MDCO's Pipeline Dec 27 2013
    Pipeline Update on Santarus Candidate Dec 26 2013
    Update on ARIAD's Iclusig Dec 26 2013
    G-III Apparel Group Set to Join the S&P SmallCap 600 Dec 23 2013
    Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis Dec 23 2013
    Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis Dec 23 2013
    Salix Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of... Dec 10 2013
    Leveraged Loan Volume Surges To $21B As Issuers Race to Year-End Dec 06 2013
    Salix Pharmaceuticals Commences Cash Tender Offer for All Outstanding Shares of Santarus Dec 03 2013
    Santarus: To Hold Or Take Profits Now? Nov 16 2013

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide